Improving pediatric multiple sclerosis interventional phase III study design: a meta-analysis

BACKGROUND: To support innovative trial designs in a regulatory setting for pediatric-onset multiple sclerosis (MS), the study aimed to perform a systematic literature review and meta-analysis of relapse rates with interferon β (IFN β), fingolimod, and natalizumab and thereby demonstrate potential b...

Descripción completa

Detalles Bibliográficos
Autores principales: Graves, Jennifer S., Thomas, Marius, Li, Jun, Shah, Anuja R., Goodyear, Alexandra, Lange, Markus R., Schmidli, Heinz, Häring, Dieter A., Friede, Tim, Gärtner, Jutta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066624/
https://www.ncbi.nlm.nih.gov/pubmed/35514529
http://dx.doi.org/10.1177/17562864211070449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066624/
https://www.ncbi.nlm.nih.gov/pubmed/35514529
http://dx.doi.org/10.1177/17562864211070449

Ejemplares similares